Comments on article by Tran and associates, "Double-blind comparison of olanzapine versus risperidone in treatment of schizophrenia and other psychotic disorders" - Reply - Letter to the editor

被引:10
|
作者
Tollefson, GD [1 ]
Tran, PV [1 ]
机构
[1] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Div Clin Res, Indianapolis, IN 46285 USA
关键词
D O I
10.1097/00004714-199804000-00016
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:177 / 179
页数:3
相关论文
共 50 条
  • [31] A double-blind, controlled study of sertindole versus risperidone in the treatment of moderate-to-severe schizophrenia
    Azorin, JM
    Strub, N
    Loft, H
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2006, 21 (01) : 49 - 56
  • [32] A double-blind, randomized comparative trial of amisulpride versus olanzapine for 6 months in the treatment of schizophrenia
    Mortimer, A
    Martin, S
    Lôo, H
    Peuskens, J
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2004, 19 (02) : 63 - 69
  • [33] A 28-Week, Randomized, Double-Blind Study of Olanzapine Versus Aripiprazole in the Treatment of Schizophrenia
    Kane, John M.
    Osuntokun, Olawale
    Kryzhanovskaya, Ludmila A.
    Xu, Wen
    Stauffer, Virginia L.
    Watson, Susan B.
    Breier, Alan
    JOURNAL OF CLINICAL PSYCHIATRY, 2009, 70 (04) : 572 - 581
  • [34] A double-blind comparison of clozapine and risperidone on spatial working memory in treatment-resistant schizophrenia
    McGurk, SR
    Goldman, RS
    Carter, C
    Green, MF
    Schooler, NR
    Marder, SR
    Kane, JM
    SCHIZOPHRENIA RESEARCH, 2001, 49 (1-2) : 238 - 238
  • [35] Olanzapine versus risperidone in the treatment of manic or mixed states in bipolar I disorder: A randomized, double-blind trial
    Perlis, Roy H.
    Baker, Robert W.
    Zarate, Carlos A., Jr.
    Brown, Eileen B.
    Schuh, Leslie M.
    Jamal, Hassan H.
    Tohen, Mauricio
    JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (11) : 1747 - 1753
  • [36] A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder (vol 158, pg 765, 2001)
    Conley, RR
    Mahmoud, R
    AMERICAN JOURNAL OF PSYCHIATRY, 2001, 158 (10): : 1759 - 1759
  • [37] Risperidone versus haloperidol in the treatment of acute exacerbations of chronic inpatients with schizophrenia: a randomized double-blind study
    Zhang, XY
    Zhou, DF
    Cao, LY
    Zhang, PY
    Wu, GY
    Shen, YC
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2001, 16 (06) : 325 - 330
  • [38] Double-blind comparison of olanzapine versus clozapine in schizophrenic patients clinically eligible for treatment with clozapine
    Tollefson, GD
    Birkett, MA
    Kiesler, GM
    Wood, AJ
    BIOLOGICAL PSYCHIATRY, 2001, 49 (01) : 52 - 63
  • [39] Olanzapine versus haloperidol in the treatment of schizophrenia and other psychotic disorders: Quality of life and clinical outcomes of a randomized clinical trial
    Dennis A. Revicki
    Laura A. Genduso
    Susan H. Hamilton
    Dara Ganoczy
    Charles M. Beasley
    Quality of Life Research, 1999, 8 : 417 - 426
  • [40] Olanzapine versus haloperidol in the treatment of schizophrenia and other psychotic disorders: Quality of life and clinical outcomes of a randomized clinical trial
    Revicki, DA
    Genduso, LA
    Hamilton, SH
    Ganoczy, D
    Beasley, CM
    QUALITY OF LIFE RESEARCH, 1999, 8 (05) : 417 - 426